Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1999
12/22/1999EP0726954B1 Cytokine antagonists
12/22/1999EP0725817A4 Embryonic stem cells capable of differentiating into desired cell lines
12/22/1999CN1239512A Replication-competent recombinant sabin type 1 strain of pollovirus
12/22/1999CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999CN1239509A Waxy wheat starch types having waxy proteins in granule
12/22/1999CN1239480A Pharmaceutical compsns. containing an MPL ligand
12/22/1999CN1239479A Mage-1- encoding cDNA, tumor rejection antigen precursor mage-10, antibodies specific to molecule, and uses thereof
12/22/1999CN1239431A Immunogenic TLP compsn.
12/22/1999CN1239143A Method for producing nucleic acid substances
12/22/1999CN1239103A Process for preparing recombined human serum albumin
12/22/1999CN1238990A Pigment marked protein composite and its preparing method
12/22/1999CN1047630C Method and reagents for hepatitis C detection
12/21/1999US6005092 Arabidopsis thaliana endo-1,4-β-glucanase gene and promoter
12/21/1999US6005089 Nucleotide sequence which hybridizes to major platelet membrane protein; for diagnosis and gene therapy of related diseases; for detection of cells of megakaryoblastic lineage in humans
12/21/1999US6005088 Gene useful as an indicator in the prophylaxis, diagnosis and treatment of diseases in humans such as cancer and hereditary diseases
12/21/1999US6005086 Wherein said polypeptide is a nuclear receptor and is responsive to the presence of farnesoid to regulate the transcription of associated gene(s)
12/21/1999US6005082 Process for purification of factor VIII
12/21/1999US6005081 Purification of recombinant human neurotrophins
12/21/1999US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999US6005077 Use of von willebrand factor and pharmaceutical formulation
12/21/1999US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999US6005074 Cloning of human GPR14 receptor
12/21/1999US6005072 Proteins closely related to opioid receptors
12/21/1999US6005071 Specific region of hirudin that is responsible, at least in part, for its anticoagulant activity
12/21/1999US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999US6004941 Introducing nucleic acid encoding fusion protein which activates transcription and comprises a polypeptide that binds to tetracycline operator
12/21/1999US6004937 Treating muscular and nervous system disorders
12/21/1999US6004931 Method for inhibiting growth hormone action
12/21/1999US6004930 Administering gamma zein protein with phenylalanine amino acids removed; phenylketonuria treatment; eliminated codons
12/21/1999US6004929 Biologically active PDGF A-chain homodimers
12/21/1999US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999US6004924 Protein sequences of serrate gene products
12/21/1999US6004824 Propoxyphene derivatives for immunoassay reagents
12/21/1999US6004813 Il-6 activity inhibitor
12/21/1999US6004811 Isolated cytotoxic t-cell which expresses a membrane-bound chimeric receptor which binds target cell and signals to destroy bound target cell; targets infected, cancerous, tumor or autoimmune-generated cells
12/21/1999US6004808 Promiscuous G-protein compositions and their use
12/21/1999US6004805 Transcriptional enhancer from milk protein genes
12/21/1999US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999US6004799 Recombinant live feline immunodeficiency virus and proviral DNA vaccines
12/21/1999US6004797 Adenovirus helper-free recombinant AAV Virion production
12/21/1999US6004791 Amino acid sequence of polypeptide involved in controlling growth factor stimulation of cellular differentiation; for anticarcinogenic agnents and treatment of neural injuries
12/21/1999US6004782 Hyperexpression of bioelastic polypeptides
12/21/1999US6004781 Fusion protein of immunoglobulin heavy chain whose variable region has been replaced by amino acids 1-173 of cd4; viricides for treatment of human immunodeficiency virus and simian immunodeficiency virus; diagnosis/detection
12/21/1999US6004780 Growth factor HTTER36
12/21/1999US6004779 Regulated gene expression in yeast
12/21/1999US6004778 Amino acid sequence of a new human protein; for diagnosis, prevention, and treatment of disorders associated with cell proliferation and apoptosis; anticarcinogenic agents
12/21/1999US6004775 DNA encoding IGFBP-4
12/21/1999US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999US6004759 Methods and compositions for diagnosing autoimmune insulin dependant diabetes mellitus
12/21/1999US6004758 Method of making a regulatory peptide that modulates cell surface receptor activity of a cell surface receptor that is internalized or recycled into the cytoplasm
12/21/1999US6004756 Detecting the presence of mrna encoding a mammaglobin polypeptide in a sample from the patient
12/21/1999US6004753 Human S1-5 ECMP-like protein
12/21/1999US6004748 Inhibiting the transcription of a gene used to treat arthritis and cancer
12/21/1999US6004746 Interaction trap systems for detecting protein interactions
12/21/1999US6004586 Contacting sperm with purified polypeptide having seqeunce defined in part by truncated portion of prosaposin molecule; contacting sperm with investments of one or more oocytes
12/21/1999US6004562 Outer membrane protein B1 of Moraxella catarrhalis
12/21/1999US6004561 High level expression of polypeptide that contains modified preS1 region of hepatitis B virus large antigen
12/21/1999US6004557 Variants of human papillomavirus antigens
12/21/1999US6004556 Staphylococcus aureus RSBU-1
12/21/1999US6004555 Methods for the specific coagulation of vasculature
12/21/1999US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999US6004549 Crystalline protein controlled release compositions
12/21/1999US6004548 Polypeptides possessing primary structural conformation and biological properties of mammalian pluripotent granulocyte colony stimulating factor wherein at least one cysteine residue at positions 17,36,42,64,74 is replaced by alanine
12/21/1999US6004535 Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies
12/21/1999US6004354 IceA gene and related methods
12/21/1999CA2230245C Buchloe dactyloides extracts having insecticidal properties
12/21/1999CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/21/1999CA2143510C Method for the isolation and purification of vitamin k-dependent proteins
12/21/1999CA2122135C Recombinant core-streptavidin
12/21/1999CA2072891C Pseudomonas exotoxin fusion proteins having carboxyl alterations with increased cytotoxicity
12/21/1999CA2065287C New hcv isolates
12/21/1999CA2022942C Method of assessing sensitivity of hiv to zidovudine
12/21/1999CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/21/1999CA1340857C Synthetic plasmid transformant, feline interferon gene and method for producing feline interferon
12/21/1999CA1340855C Neurite-promoting factor and process for the manufacture thereof
12/21/1999CA1340853C Purification of recombinant interleukin-2
12/19/1999CA2273059A1 Method of dwarfing plants
12/19/1999CA2242316A1 Dna encoding a plasminogen activating protein
12/16/1999WO1999064866A1 A method of identifying ligands to rna polymerase sigma 70 subunit
12/16/1999WO1999064865A1 Assays for tsh receptor autoantibodies
12/16/1999WO1999064690A1 Fire-resisting wall
12/16/1999WO1999064633A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999WO1999064631A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
12/16/1999WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999WO1999064611A1 Mass production method of antimicrobial peptide and dna construct and expression system thereof
12/16/1999WO1999064609A1 New human carboxypeptidase inhibitor
12/16/1999WO1999064604A2 Attenuated pestiviruses
12/16/1999WO1999064603A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
12/16/1999WO1999064602A2 Moraxella catarrhalis polynucleotides and polypeptides
12/16/1999WO1999064601A1 Novel maize orthologues of bacterial reca proteins
12/16/1999WO1999064600A1 NUCLEOTIDE SEQUENCES OF THE APPLE LRPKm1 GENE, ENCODED AMINO ACID SEQUENCE AND USES THEREOF
12/16/1999WO1999064599A1 Cyclin-dependent kinase inhibitors as plant growth regulators
12/16/1999WO1999064598A2 Novel insulin analogs with enhanced zinc binding
12/16/1999WO1999064597A1 β2 MICROGLOBULIN FUSION PROTEINS AND HIGH AFFINITY VARIANTS
12/16/1999WO1999064596A2 Proteins regulating gene expression
12/16/1999WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999WO1999064594A2 Genes and gene expression products that are differentially regulated in prostate cancer
12/16/1999WO1999064593A2 Cell cycle regulation proteins